Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study

Ather Ali, Theresa R. Weiss, Anne Dutton, Douglas McKee, Kim Jones, Susmita Kashikar-Zuck, Wendy K. Silverman, Eugene D. Shapiro

    Research output: Contribution to journalArticle

    11 Citations (Scopus)

    Abstract

    Objective: To assess the feasibility of a mindfulness-based stress reduction (MBSR) program for adolescents with widespread chronic pain and other functional somatic symptoms and to make preliminary assessments of its clinical utility. Study design: Three cohorts of subjects completed an 8-week MBSR program. Child- and parent-completed measures were collected at baseline and 8 and 12 weeks later. Measures included the Functional Disability Inventory (FDI), the Fibromyalgia/Symptom Impact Questionnaire-Revised (FIQR/SIQR), the Pediatric Quality of Life Inventory, the Multidimensional Anxiety Scale (MASC2), and the Perceived Stress Scale. Subjects and parents were interviewed following the program to assess feasibility. Results: Fifteen of 18 subjects (83%) completed the 8-week program. No adverse events occurred. Compared with baseline scores, significant changes were found in mean scores on the FDI (33% improvement, P = .026), FIQR/SIQR (26% improvement, P = .03), and MASC2 (child: 12% improvement, P = .02; parent report: 17% improvement, P = .03) at 8 weeks. MASC2 scores (child and parent) and Perceived Stress Scale scores were significantly improved at 12 weeks. More time spent doing home practice was associated with better outcomes in the FDI and FIQR/SIQR (44% and 26% improvement, respectively). Qualitative interviews indicated that subjects and parents reported social support as a benefit of the MBSR class, as well as a positive impact of MBSR on activities of daily living, and on pain and anxiety. Conclusions: MBSR is a feasible and acceptable intervention in adolescents with functional somatic syndromes and has preliminary evidence for improving functional disability, symptom impact, and anxiety, with consistency between parent and child measures. Trial registration: ClinicalTrials.gov: NCT02190474.

    Original languageEnglish (US)
    JournalJournal of Pediatrics
    DOIs
    StateAccepted/In press - Aug 31 2016

    Fingerprint

    Mindfulness
    Cohort Studies
    Equipment and Supplies
    Anxiety
    Parents
    Fibromyalgia
    Activities of Daily Living
    Chronic Pain
    Social Support
    Quality of Life
    Interviews
    Pediatrics
    Pain

    Keywords

    • Chronic pain
    • Fibromyalgia
    • Irritable bowel syndrome
    • Quality of life

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health

    Cite this

    Ali, A., Weiss, T. R., Dutton, A., McKee, D., Jones, K., Kashikar-Zuck, S., ... Shapiro, E. D. (Accepted/In press). Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study. Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2016.12.053

    Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes : A Pilot Cohort Study. / Ali, Ather; Weiss, Theresa R.; Dutton, Anne; McKee, Douglas; Jones, Kim; Kashikar-Zuck, Susmita; Silverman, Wendy K.; Shapiro, Eugene D.

    In: Journal of Pediatrics, 31.08.2016.

    Research output: Contribution to journalArticle

    Ali, Ather ; Weiss, Theresa R. ; Dutton, Anne ; McKee, Douglas ; Jones, Kim ; Kashikar-Zuck, Susmita ; Silverman, Wendy K. ; Shapiro, Eugene D. / Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes : A Pilot Cohort Study. In: Journal of Pediatrics. 2016.
    @article{412f4b68b1cc4557ba18de1ae109ea82,
    title = "Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study",
    abstract = "Objective: To assess the feasibility of a mindfulness-based stress reduction (MBSR) program for adolescents with widespread chronic pain and other functional somatic symptoms and to make preliminary assessments of its clinical utility. Study design: Three cohorts of subjects completed an 8-week MBSR program. Child- and parent-completed measures were collected at baseline and 8 and 12 weeks later. Measures included the Functional Disability Inventory (FDI), the Fibromyalgia/Symptom Impact Questionnaire-Revised (FIQR/SIQR), the Pediatric Quality of Life Inventory, the Multidimensional Anxiety Scale (MASC2), and the Perceived Stress Scale. Subjects and parents were interviewed following the program to assess feasibility. Results: Fifteen of 18 subjects (83{\%}) completed the 8-week program. No adverse events occurred. Compared with baseline scores, significant changes were found in mean scores on the FDI (33{\%} improvement, P = .026), FIQR/SIQR (26{\%} improvement, P = .03), and MASC2 (child: 12{\%} improvement, P = .02; parent report: 17{\%} improvement, P = .03) at 8 weeks. MASC2 scores (child and parent) and Perceived Stress Scale scores were significantly improved at 12 weeks. More time spent doing home practice was associated with better outcomes in the FDI and FIQR/SIQR (44{\%} and 26{\%} improvement, respectively). Qualitative interviews indicated that subjects and parents reported social support as a benefit of the MBSR class, as well as a positive impact of MBSR on activities of daily living, and on pain and anxiety. Conclusions: MBSR is a feasible and acceptable intervention in adolescents with functional somatic syndromes and has preliminary evidence for improving functional disability, symptom impact, and anxiety, with consistency between parent and child measures. Trial registration: ClinicalTrials.gov: NCT02190474.",
    keywords = "Chronic pain, Fibromyalgia, Irritable bowel syndrome, Quality of life",
    author = "Ather Ali and Weiss, {Theresa R.} and Anne Dutton and Douglas McKee and Kim Jones and Susmita Kashikar-Zuck and Silverman, {Wendy K.} and Shapiro, {Eugene D.}",
    year = "2016",
    month = "8",
    day = "31",
    doi = "10.1016/j.jpeds.2016.12.053",
    language = "English (US)",
    journal = "Journal of Pediatrics",
    issn = "0022-3476",
    publisher = "Mosby Inc.",

    }

    TY - JOUR

    T1 - Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes

    T2 - A Pilot Cohort Study

    AU - Ali, Ather

    AU - Weiss, Theresa R.

    AU - Dutton, Anne

    AU - McKee, Douglas

    AU - Jones, Kim

    AU - Kashikar-Zuck, Susmita

    AU - Silverman, Wendy K.

    AU - Shapiro, Eugene D.

    PY - 2016/8/31

    Y1 - 2016/8/31

    N2 - Objective: To assess the feasibility of a mindfulness-based stress reduction (MBSR) program for adolescents with widespread chronic pain and other functional somatic symptoms and to make preliminary assessments of its clinical utility. Study design: Three cohorts of subjects completed an 8-week MBSR program. Child- and parent-completed measures were collected at baseline and 8 and 12 weeks later. Measures included the Functional Disability Inventory (FDI), the Fibromyalgia/Symptom Impact Questionnaire-Revised (FIQR/SIQR), the Pediatric Quality of Life Inventory, the Multidimensional Anxiety Scale (MASC2), and the Perceived Stress Scale. Subjects and parents were interviewed following the program to assess feasibility. Results: Fifteen of 18 subjects (83%) completed the 8-week program. No adverse events occurred. Compared with baseline scores, significant changes were found in mean scores on the FDI (33% improvement, P = .026), FIQR/SIQR (26% improvement, P = .03), and MASC2 (child: 12% improvement, P = .02; parent report: 17% improvement, P = .03) at 8 weeks. MASC2 scores (child and parent) and Perceived Stress Scale scores were significantly improved at 12 weeks. More time spent doing home practice was associated with better outcomes in the FDI and FIQR/SIQR (44% and 26% improvement, respectively). Qualitative interviews indicated that subjects and parents reported social support as a benefit of the MBSR class, as well as a positive impact of MBSR on activities of daily living, and on pain and anxiety. Conclusions: MBSR is a feasible and acceptable intervention in adolescents with functional somatic syndromes and has preliminary evidence for improving functional disability, symptom impact, and anxiety, with consistency between parent and child measures. Trial registration: ClinicalTrials.gov: NCT02190474.

    AB - Objective: To assess the feasibility of a mindfulness-based stress reduction (MBSR) program for adolescents with widespread chronic pain and other functional somatic symptoms and to make preliminary assessments of its clinical utility. Study design: Three cohorts of subjects completed an 8-week MBSR program. Child- and parent-completed measures were collected at baseline and 8 and 12 weeks later. Measures included the Functional Disability Inventory (FDI), the Fibromyalgia/Symptom Impact Questionnaire-Revised (FIQR/SIQR), the Pediatric Quality of Life Inventory, the Multidimensional Anxiety Scale (MASC2), and the Perceived Stress Scale. Subjects and parents were interviewed following the program to assess feasibility. Results: Fifteen of 18 subjects (83%) completed the 8-week program. No adverse events occurred. Compared with baseline scores, significant changes were found in mean scores on the FDI (33% improvement, P = .026), FIQR/SIQR (26% improvement, P = .03), and MASC2 (child: 12% improvement, P = .02; parent report: 17% improvement, P = .03) at 8 weeks. MASC2 scores (child and parent) and Perceived Stress Scale scores were significantly improved at 12 weeks. More time spent doing home practice was associated with better outcomes in the FDI and FIQR/SIQR (44% and 26% improvement, respectively). Qualitative interviews indicated that subjects and parents reported social support as a benefit of the MBSR class, as well as a positive impact of MBSR on activities of daily living, and on pain and anxiety. Conclusions: MBSR is a feasible and acceptable intervention in adolescents with functional somatic syndromes and has preliminary evidence for improving functional disability, symptom impact, and anxiety, with consistency between parent and child measures. Trial registration: ClinicalTrials.gov: NCT02190474.

    KW - Chronic pain

    KW - Fibromyalgia

    KW - Irritable bowel syndrome

    KW - Quality of life

    UR - http://www.scopus.com/inward/record.url?scp=85009433843&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85009433843&partnerID=8YFLogxK

    U2 - 10.1016/j.jpeds.2016.12.053

    DO - 10.1016/j.jpeds.2016.12.053

    M3 - Article

    C2 - 28088398

    AN - SCOPUS:85009433843

    JO - Journal of Pediatrics

    JF - Journal of Pediatrics

    SN - 0022-3476

    ER -